Literature DB >> 18635153

A pilot study of Fourier-domain optical coherence tomography of retinal dystrophy patients.

Jennifer I Lim1, Ou Tan, Amani A Fawzi, J Jill Hopkins, John H Gil-Flamer, David Huang.   

Abstract

PURPOSE: To characterize the macular anatomy of retinal dystrophy eyes using high-speed, high-resolution, Fourier-domain optical coherence tomography (FD-OCT).
DESIGN: Case-control study.
METHODS: Retinal dystrophy patients and normal age- and gender-matched controls underwent FD-OCT imaging using the RTVue (Optovue Inc., Fremont, California, USA). Vertical and horizontal 8-mm scans of 1024 lines/cross-section were obtained. Based on boundaries manually drawn on computer displays of OCT cross-sections, the thicknesses of the retina, inner retinal layer (IRL), and outer retinal layer (ORL) were averaged over both 5-mm (macular) and 1.5-mm (foveal) regions centered at the fovea. The IRL was the sum of nerve fiber layer (NFL), ganglion cell layer (GCL), and inner plexiform layer (IPL) thicknesses. Total retinal thickness (RT) was measured between the internal limiting membrane (ILM) and the retinal pigment epithelium. ORL thickness was calculated by subtracting IRL thickness from RT.
RESULTS: Fourteen patients (three retinitis pigmentosa, two cone-rod degeneration, two Stargardt disease, and seven normal controls) underwent FD-OCT imaging. Mean foveal RT was 271.3 +/- 23.3 microm for controls and 158.4 +/- 47.1 microm for retinal dystrophy patients (P < .001). Mean macular RT was 292.8 +/- 8.1 microm for controls and 199.1 +/- 32.6 microm for retinal dystrophy patients (P < .001). Mean macular ORL was 182.9 +/- 4.7 microm for controls and 101.3 +/- 18.7 microm for retinal dystrophy patients (P < .001); mean macular IRL was 109.9 +/- 6.4 microm for controls and 97.9 +/- 20.7 microm for retinal dystrophy patients (P = .06).
CONCLUSION: Eyes with retinal dystrophy had a small (11%) decrease in macular IRL and severe (45%) decrease in macular ORL compared to normal controls.

Entities:  

Mesh:

Year:  2008        PMID: 18635153      PMCID: PMC2654420          DOI: 10.1016/j.ajo.2008.05.018

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

1.  Ultrahigh-resolution ophthalmic optical coherence tomography.

Authors:  W Drexler; U Morgner; R K Ghanta; F X Kärtner; J S Schuman; J G Fujimoto
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

2.  Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography.

Authors:  Wolfgang Drexler; Harald Sattmann; Boris Hermann; Tony H Ko; Michael Stur; Angelika Unterhuber; Christoph Scholda; Oliver Findl; Matthias Wirtitsch; James G Fujimoto; Adolf F Fercher
Journal:  Arch Ophthalmol       Date:  2003-05

3.  In vivo human retinal imaging by Fourier domain optical coherence tomography.

Authors:  Maciej Wojtkowski; Rainer Leitgeb; Andrzej Kowalczyk; Tomasz Bajraszewski; Adolf F Fercher
Journal:  J Biomed Opt       Date:  2002-07       Impact factor: 3.170

4.  Buffered Fourier domain mode locking: Unidirectional swept laser sources for optical coherence tomography imaging at 370,000 lines/s.

Authors:  Robert Huber; Desmond C Adler; James G Fujimoto
Journal:  Opt Lett       Date:  2006-10-15       Impact factor: 3.776

5.  Sensitivity advantage of swept source and Fourier domain optical coherence tomography.

Authors:  Michael Choma; Marinko Sarunic; Changhuei Yang; Joseph Izatt
Journal:  Opt Express       Date:  2003-09-08       Impact factor: 3.894

6.  Performance of fourier domain vs. time domain optical coherence tomography.

Authors:  R Leitgeb; C Hitzenberger; Adolf Fercher
Journal:  Opt Express       Date:  2003-04-21       Impact factor: 3.894

7.  Optical coherence tomography.

Authors:  D Huang; E A Swanson; C P Lin; J S Schuman; W G Stinson; W Chang; M R Hee; T Flotte; K Gregory; C A Puliafito
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

8.  Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology.

Authors:  Tony H Ko; James G Fujimoto; Joel S Schuman; Lelia A Paunescu; Andrew M Kowalevicz; Ingmar Hartl; Wolfgang Drexler; Gadi Wollstein; Hiroshi Ishikawa; Jay S Duker
Journal:  Ophthalmology       Date:  2005-09-23       Impact factor: 12.079

9.  Ultra-high resolution optical coherence tomography assessment of photoreceptors in retinitis pigmentosa and related diseases.

Authors:  Andre J Witkin; Tony H Ko; James G Fujimoto; Annie Chan; Wolfgang Drexler; Joel S Schuman; Elias Reichel; Jay S Duker
Journal:  Am J Ophthalmol       Date:  2006-09-01       Impact factor: 5.258

10.  Assessment of central visual function in Stargardt's disease/fundus flavimaculatus with ultrahigh-resolution optical coherence tomography.

Authors:  Erdem Ergun; Boris Hermann; Matthias Wirtitsch; Angelika Unterhuber; Tony H Ko; Harald Sattmann; Christoph Scholda; James G Fujimoto; Michael Stur; Wolfgang Drexler
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-01       Impact factor: 4.799

View more
  35 in total

1.  Reliability of a computer-aided manual procedure for segmenting optical coherence tomography scans.

Authors:  Donald C Hood; Jungsuk Cho; Ali S Raza; Elizabeth A Dale; Min Wang
Journal:  Optom Vis Sci       Date:  2011-01       Impact factor: 1.973

2.  Choroidal imaging in inherited retinal disease using the technique of enhanced depth imaging optical coherence tomography.

Authors:  Jonathan Yeoh; Waheeda Rahman; Fred Chen; Claire Hooper; Praveen Patel; Adnan Tufail; Andrew R Webster; Anthony T Moore; Lyndon Dacruz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-17       Impact factor: 3.117

3.  Comparison of clinically relevant findings from high-speed fourier-domain and conventional time-domain optical coherence tomography.

Authors:  Pearse A Keane; Rizwan A Bhatti; Jacob W Brubaker; Sandra Liakopoulos; Srinivas R Sadda; Alexander C Walsh
Journal:  Am J Ophthalmol       Date:  2009-05-09       Impact factor: 5.258

4.  Progression of Anterograde Trans-Synaptic Degeneration in the Human Retina Is Modulated by Axonal Convergence and Divergence.

Authors:  E L Panneman; D Coric; L M D Tran; W A E J de Vries-Knoppert; A Petzold
Journal:  Neuroophthalmology       Date:  2019-05-27

5.  Interchangeability of macular thickness measurements between different volumetric protocols of Spectralis optical coherence tomography in normal eyes.

Authors:  Yaroslava Wenner; Stephan Wismann; Melanie Jäger; Jörn Pons-Kühnemann; Birgit Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-02-20       Impact factor: 3.117

6.  Intra-examiner repeatability and agreement of corneal pachymetry map measurement by time-domain and Fourier-domain optical coherence tomography.

Authors:  Jehn-Yu Huang; Melike Pekmezci; Stephanie Yaplee; Shan Lin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-30       Impact factor: 3.117

7.  The structure and function of the macula in patients with advanced retinitis pigmentosa.

Authors:  Rita Vámos; Erika Tátrai; János Németh; Graham E Holder; Delia Cabrera DeBuc; Gábor Márk Somfai
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-28       Impact factor: 4.799

8.  Multimodal imaging of foveal cavitation in retinal dystrophies.

Authors:  Maurizio Battaglia Parodi; Maria Vittoria Cicinelli; Pierluigi Iacono; Gianluigi Bolognesi; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-05       Impact factor: 3.117

9.  Measurement of macular thickness with optical coherence tomography: impact of using a paediatric reference database and analysis of interocular symmetry.

Authors:  Alicia Muñoz-Gallego; José L Torres-Peña; Martín Rodríguez-Salgado; Ana Ortueta-Olartecoechea; Cristina López-López; Javier De la Cruz; Pilar Tejada-Palacios
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-08-29       Impact factor: 3.117

10.  Morphologic characteristics of the outer retina in cone dystrophy on spectral-domain optical coherence tomography.

Authors:  Soo Chang Cho; Se Joon Woo; Kyu Hyung Park; Jeong-Min Hwang
Journal:  Korean J Ophthalmol       Date:  2013-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.